Continuous extraovular administration of prostaglandin F2alpha for midtrimester abortion.
D000028:Abortion, Induced; D000293:Adolescent; D000328:Adult; D004716:Endometritis / Q000139:chemically induced; D005260:Female; D005313:Fetal Death / Q000601:surgery; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007751:Labor, Induced; D010298:Parity; D011225:Pre-Eclampsia / Q000601:surgery; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011374:Progesterone / Q000097:blood; D011453:Prostaglandins / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors; D014599:Uterus / Q000187:drug effects / Q000503:physiopathology
D011453:Prostaglandins; D011374:Progesterone; D006854:Hydrocortisone